NL-OMON52098尚未招募2 期
Precision Radiotherapy using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 patients - PRIME study
niversitair Medisch Centrum Utrecht0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •MEN1 patients diagnosed with pNET meeting the following criteria:
- •- lesions measuring between 2cm and 3cm.
- •- pNET lesions with a size between 1.0 and 2.0 cm and moderate growth of the
- •lesion (2-4 mm/ year) on sequential follow-up scans.
- •- pNET lesions with a size between 1.0 and 2.0 cm and minimal growth of the
- •lesion (1 mm/ year) reconfirmed on 3 or more sequential follow-up scans.
- •- Patients with in situ remaining 1.0 - 2.0 cm lesions after previous resection
- •of a larger lesion.
排除标准
- •- Suspected malignant pNET as per the tumour board assessment, including the
- •- pNET lesions of more than 3 cm in size
- •- rapid growth of pNET lesions with more than 4mm per year
- •- Symptomatic pNET because of hormone production, with the exception of
- •gastrinomas which are located in the submucosa of the duodenum
- •- concurrent treatment with a somatostatin analog
- •- concurrent treatment with chemotherapy
- •- peptide receptor radionuclide therapy in the past 12 months
- •- history of radiotherapy in the upper abdominal region
- •- MRI contraindications as per usual clinical care, such as claustrophobia and
- •metal or electronic implants not compatible with MRI.
- •- Pregnancy
- •- (Other) metastatic disease
- •- WHO performance score 3-4
研究者
相似试验
尚未招募
不适用
Locally Advanced Pancreatic Cancer Treated With ABLAtivE Stereotactic MRI-guided Adaptive Radiation TherapyPancreatic CancerNCT05585554Viewray Inc.267
已完成
2 期
MR Guided Phase II Radiotherapy Dose Escalation in Unresectable Non-Metastatic Pancreatic CancerUnresectable Pancreatic CancerNCT01972919Medical College of Wisconsin23
尚未招募
不适用
MRI-Linac treatment for radiotherapy patients. A study on the use of the Australian MRI-Linac to treat cancer radiotherapy patientsCancer requiring palliative radiotherapyCancer - Any cancerACTRN12621000418875South Western Sydney Local Health District10
进行中（未招募）
不适用
Radio-/Chemotherapie des PankreaskarzinomsRadio-/Chemotherapy of pancreas carcinoma - PaCaEUCTR2009-011968-11-DETechnische Universität Dresden
招募中
1 期
Dose-Painted Intensity Modulated Radiotherapy Pancreas (DP-IMRT Pancreas)Pancreatic AdenocarcinomaNCT06024824Cancer Trials Ireland49